Latest Schedule 13G passive stakes

Janus Henderson Group Ltd. has disclosed beneficial ownership of 9.99% of Yarrow Bioscience, Inc.'s common stock, holding 266,712 shares and pre-funded warrants.

Janus Henderson Group Ltd. has disclosed beneficial ownership of 9.99% of Yarrow Bioscience, Inc.'s common stock, holding 266,712 shares and pre-funded warrants.

Janus Henderson Group Ltd. has filed an amendment to its Schedule 13G, reporting a decrease in its beneficial ownership of Vaxcyte, Inc. common stock.

Janus Henderson Group Ltd. has filed an amendment to its Schedule 13G, reporting a decrease in its beneficial ownership of Vaxcyte, Inc. common stock.

Janus Henderson Group Ltd. has updated its beneficial ownership filing for Forte Biosciences, Inc., reporting a 2.5% stake.

Janus Henderson Group Ltd. has updated its beneficial ownership filing for Forte Biosciences, Inc., reporting a 2.5% stake.

HSBC Holdings plc has updated its beneficial ownership filing for Wix.com Ltd., reporting a 0.5% stake.

HSBC Holdings plc has updated its beneficial ownership filing for Wix.com Ltd., reporting a 0.5% stake.

Linden Capital L.P. and affiliated entities have filed a Schedule 13G, reporting beneficial ownership of 5.3% to 5.5% of Spartacus Acquisition Corp. II's Class A Ordinary Shares as of August 3, 2026.

State Street Corporation and its affiliate SSGA Funds Management, Inc. have filed a Schedule 13G, disclosing a passive, non-controlling ownership of 0.1% in Astronix Corp.

State Street Corporation and its affiliate SSGA Funds Management, Inc. have filed a Schedule 13G, disclosing a passive, non-controlling ownership of 0.1% in Astronix Corp.

State Street Corporation has reported a beneficial ownership of 6.5% in World Kinect Corp's common stock as of June 30, 2026.

State Street Corporation has reported a beneficial ownership of 6.5% in World Kinect Corp's common stock as of June 30, 2026.

Aristotle Capital Management, LLC has updated its Schedule 13G filing to reflect its beneficial ownership of 1,217,877 shares of Oshkosh Corporation common stock, representing 1.97% of the class.

Several Merck-affiliated entities have jointly filed a Schedule 13G, reporting a combined 4.9% beneficial ownership of Precigen, Inc. common stock.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting beneficial ownership of 18,068,665.21 shares, representing 13.2% of Leggett & Platt Inc.'s common stock.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 10.0% of Relay Therapeutics Inc.'s common stock as of July 31, 2026.

State Street Corporation has updated its Schedule 13G filing to reflect its beneficial ownership of Wolfspeed Inc. common stock as of June 30, 2026.

State Street Corporation has updated its Schedule 13G filing to reflect its beneficial ownership of Wolfspeed Inc. common stock as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for Williams-Sonoma Inc., reporting a significant stake in the company's common stock.

State Street Corporation has updated its beneficial ownership filing for Williams-Sonoma Inc., reporting a significant stake in the company's common stock.

FMR LLC has reported a beneficial ownership of 10.3% in Kardigan Inc. as of July 31, 2026, indicating a substantial institutional holding.

State Street Corporation has updated its Schedule 13G filing to report beneficial ownership of 5.9% of Westamerica Bancorp's common stock.

State Street Corporation has updated its Schedule 13G filing to report beneficial ownership of 5.9% of Westamerica Bancorp's common stock.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 12.0% of VOR BIOPHARMA INC's common stock as of July 31, 2026.

State Street Corporation has disclosed beneficial ownership of 5,616,212 shares, representing 5.8% of Wesbanco Inc.'s common stock, as of June 30, 2026.

State Street Corporation has disclosed beneficial ownership of 5,616,212 shares, representing 5.8% of Wesbanco Inc.'s common stock, as of June 30, 2026.

State Street Corporation has updated its beneficial ownership filing for Vistra Corp, reporting a significant stake in the company's common stock.

State Street Corporation has updated its beneficial ownership filing for Vistra Corp, reporting a significant stake in the company's common stock.

State Street Corporation has disclosed beneficial ownership of 5.5% of Viridian Therapeutics Inc.'s common stock as of June 30, 2026.